Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial Studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients With Type II Diabetes and Insulin Resistance Undergoing Elective PTCA. A Randomized Double-blinded Phase II Study.

NCT00771004 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00771004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00771004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial Studying the Effects of Pioglitazone in Comparison to Placebo on Myocardial Function and Oxidative Stress in Patients With Type II Diabetes and Insulin Resistance Undergoing Elective PTCA. A Randomized Double-blinded Phase II Study.
Lead sponsor
Takeda
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
February 28, 2009
Enrollment
63 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, oxidative stress, type 2 diabetes